Swiss drugmaker Roche Holding AG has dropped its plans to develop and sell a diabetes treatment with Chugai Pharmaceutical and has handed back the overseas rights, the Japanese drugmaker said today.

The drug CSG452 was dropped after a review by Roche of its pipeline, Chugai said.

Chugai said it will consider other partners to help it develop the drug and has not changed its plans to submit it for approval to Japanese health authorities in 2013.

Reuters